BackOrion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) Overview

Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) Total Current Liabilities

Track Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War)'s total current liabilities ($68K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$67593.00
17.20% YoYΔ $-14038.00 vs prior year quarter

Peer average

Loading

Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) Total Current Liabilities History

Loading

Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) vs. peers: Total Current Liabilities Comparison

Loading

Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War) (ORIAU) FAQ

The latest total current liabilities for ORIAU is $68K as of December 2022. That compares with $82K in the prior-year period — down 17.2% year over year. Investors often review this figure alongside Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, ORIAU's total current liabilities moved from $82K to $68K — a 17.2% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Orion Biotech Opportunities - Units (1 Ord Share Class A & 1/5 War)'s operating scale or balance-sheet position.

A total current liabilities figure of $68K for ORIAU is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ORIAU's total current liabilities ($68K), review year-over-year change from $82K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.